• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G-四链体结合剂在侵袭性乳腺癌细胞中诱导免疫原性细胞死亡标志物。

G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer Cells.

作者信息

Di Somma Sarah, Amato Jussara, Iaccarino Nunzia, Pagano Bruno, Randazzo Antonio, Portella Giuseppe, Malfitano Anna Maria

机构信息

Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.

Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.

出版信息

Cancers (Basel). 2019 Nov 15;11(11):1797. doi: 10.3390/cancers11111797.

DOI:10.3390/cancers11111797
PMID:31731707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6895816/
Abstract

BACKGROUND

DNA G-quadruplex (G4) structures represent potential anti-cancer targets. In this study, we compared the effect of two G4-targeting compounds, C066-3108 and the gold standard BRACO-19.

METHODS

In breast and prostate cancer cells, cytotoxicity induced by both molecules was measured by a sulforhodamine B assay. In breast cancer cells, cycle, apoptosis, the formation of G4 structures, calreticulin and high mobility group box 1 (HMGB1), as well as T cell activation, were analyzed by flow cytometry and adenosine triphosphate (ATP) by luminescence.

RESULTS

Both ligands inhibited cell survival and induced DNA damage. In MCF-7 cells, G4 ligands increased the subG0/G1 phase of the cell cycle inducing apoptosis and reduced intracellular ATP. In untreated MCF-7 cells, we observed a slight presence of G4 structures associated with the G2/M phase. In MDA-MB231 cells, G4 ligands decreased the G1 and enhanced the G2/M phase. We observed a decrease of intracellular ATP, calreticulin cell surface exposure and an increase of HMGB1, accompanied by T cell activation. Both compounds induced G4 structure formation in the subG0/G1 phase.

CONCLUSIONS

Our data report similar effects for both compounds and the first evidence that G4 ligands induce the release of danger signals associated with immunogenic cell death and induction of T cell activation.

摘要

背景

DNA G-四链体(G4)结构是潜在的抗癌靶点。在本研究中,我们比较了两种靶向G4的化合物C066-3108和金标准化合物BRACO-19的作用效果。

方法

在乳腺癌和前列腺癌细胞中,通过磺酰罗丹明B测定法检测两种分子诱导的细胞毒性。在乳腺癌细胞中,通过流式细胞术分析细胞周期、凋亡、G4结构的形成、钙网蛋白和高迁移率族蛋白B1(HMGB1),并通过发光法检测三磷酸腺苷(ATP)。

结果

两种配体均抑制细胞存活并诱导DNA损伤。在MCF-7细胞中,G4配体增加了细胞周期的亚G0/G1期,诱导凋亡并降低细胞内ATP。在未处理的MCF-7细胞中,我们观察到与G2/M期相关的G4结构略有存在。在MDA-MB231细胞中,G4配体减少了G1期并增强了G2/M期。我们观察到细胞内ATP减少、钙网蛋白细胞表面暴露减少以及HMGB1增加,同时伴有T细胞活化。两种化合物均在亚G0/G1期诱导G4结构形成。

结论

我们的数据报告了两种化合物的相似作用效果,并且首次证明G4配体诱导与免疫原性细胞死亡相关的危险信号释放并诱导T细胞活化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/f4349ce52dca/cancers-11-01797-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/aa873541bba3/cancers-11-01797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/0451bd33d681/cancers-11-01797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/8fe9cf2b81fa/cancers-11-01797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/7635a7529e4b/cancers-11-01797-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/0549ad8ab251/cancers-11-01797-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/97b187c567f8/cancers-11-01797-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/f4349ce52dca/cancers-11-01797-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/aa873541bba3/cancers-11-01797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/0451bd33d681/cancers-11-01797-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/8fe9cf2b81fa/cancers-11-01797-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/7635a7529e4b/cancers-11-01797-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/0549ad8ab251/cancers-11-01797-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/97b187c567f8/cancers-11-01797-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1b/6895816/f4349ce52dca/cancers-11-01797-g007a.jpg

相似文献

1
G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer Cells.G-四链体结合剂在侵袭性乳腺癌细胞中诱导免疫原性细胞死亡标志物。
Cancers (Basel). 2019 Nov 15;11(11):1797. doi: 10.3390/cancers11111797.
2
Combination of Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast Cancer.溶瘤腺病毒与 G-四链体结合物联合应用揭示了其在乳腺癌中的抗肿瘤活性增强。
Cells. 2022 Aug 10;11(16):2482. doi: 10.3390/cells11162482.
3
Novel phenanthrene imidazoles as telomeric G-quadruplex ligands trigger potent immunogenic cell death in triple-negative breast cancer.新型菲并咪唑作为端粒 G-四链体配体,引发三阴性乳腺癌强烈的免疫原性细胞死亡。
Int J Biol Macromol. 2023 Sep 30;249:126068. doi: 10.1016/j.ijbiomac.2023.126068. Epub 2023 Jul 29.
4
Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.基于配体的虚拟筛选和 G4-OAS 测定的串联应用,以鉴定新型 G-四链体靶向化学型。
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1341-1352. doi: 10.1016/j.bbagen.2017.01.024. Epub 2017 Jan 24.
5
Identification of Compounds that Selectively Stabilize Specific G-Quadruplex Structures by Using a Thioflavin T-Displacement Assay as a Tool.利用硫代黄素 T 置换分析作为工具鉴定选择性稳定特定 G-四链体结构的化合物。
Chemistry. 2016 Dec 23;22(52):18932-18943. doi: 10.1002/chem.201603463. Epub 2016 Nov 15.
6
Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.菲咯啉多氮杂大环作为 G-四链体 DNA 结合物。
Org Biomol Chem. 2018 Apr 18;16(15):2776-2786. doi: 10.1039/c8ob00247a.
7
Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer.具有抗氧化活性的三芳基二阳离子 DNA 小沟结合剂在乳腺癌中显示细胞毒性并诱导细胞凋亡。
Chem Biol Interact. 2020 Jun 1;324:109087. doi: 10.1016/j.cbi.2020.109087. Epub 2020 Apr 12.
8
The Oncolytic Virus 922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth.溶瘤病毒922 - 947引发间皮瘤中的免疫原性细胞死亡并减少异种移植瘤生长。
Front Oncol. 2019 Jul 12;9:564. doi: 10.3389/fonc.2019.00564. eCollection 2019.
9
Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.用7-羧基吲哚并[3,2-b]喹啉三烷基胺衍生物靶向结肠癌细胞中的KRAS致癌基因
PLoS One. 2015 May 29;10(5):e0126891. doi: 10.1371/journal.pone.0126891. eCollection 2015.
10
Structural insights into the binding of small ligand molecules to a G-quadruplex DNA located in the HIV-1 promoter.结构洞察小分子配体与 HIV-1 启动子中 G-四链体 DNA 的结合。
J Biomol Struct Dyn. 2018 Jul;36(9):2292-2302. doi: 10.1080/07391102.2017.1358670. Epub 2017 Jul 31.

引用本文的文献

1
Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects.药物介导的 ICD 抑制乳腺癌的综合综述:机制、现状与展望。
Clin Exp Med. 2024 Sep 26;24(1):230. doi: 10.1007/s10238-024-01482-1.
2
Therapeutic Use of G4-Ligands in Cancer: State-of-the-Art and Future Perspectives.G4配体在癌症治疗中的应用:现状与未来展望
Pharmaceuticals (Basel). 2024 Jun 13;17(6):771. doi: 10.3390/ph17060771.
3
Synthesis and Molecular Dynamic Simulation of Novel Cationic and Non-cationic Pyrimidine Derivatives as Potential G-quadruplex-ligands.

本文引用的文献

1
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer.用于治疗三阴性乳腺癌的可成药分子靶点
J Breast Cancer. 2019 Sep;22(3):341-361. doi: 10.4048/jbc.2019.22.e39.
2
Insights into telomeric G-quadruplex DNA recognition by HMGB1 protein.HMGB1 蛋白对端粒 G-四链体 DNA 的识别研究进展
Nucleic Acids Res. 2019 Oct 10;47(18):9950-9966. doi: 10.1093/nar/gkz727.
3
Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia.核仁磷酸蛋白 1 羧基末端结构域在急性髓系白血病 A 型突变中的淀粉样结构的结构见解。
新型阳离子和非阳离子嘧啶衍生物的合成及分子动力学模拟作为潜在的 G-四链体配体。
Anticancer Agents Med Chem. 2024;24(15):1126-1141. doi: 10.2174/0118715206291797240523112439.
4
Targeting G-quadruplex motifs interferes with differentiation of adipose-derived mesenchymal stem cells.靶向 G-四链体结构会干扰脂肪间充质干细胞的分化。
Stem Cell Res Ther. 2023 Apr 19;14(1):98. doi: 10.1186/s13287-023-03320-9.
5
Combination of Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast Cancer.溶瘤腺病毒与 G-四链体结合物联合应用揭示了其在乳腺癌中的抗肿瘤活性增强。
Cells. 2022 Aug 10;11(16):2482. doi: 10.3390/cells11162482.
6
Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy.靶向 HMGB1:乳腺癌治疗的可行治疗策略。
Int J Biol Sci. 2022 May 9;18(8):3421-3434. doi: 10.7150/ijbs.73504. eCollection 2022.
7
G4LDB 2.2: a database for discovering and studying G-quadruplex and i-Motif ligands.G4LDB 2.2:一个用于发现和研究 G-四链体和 i-Motif 配体的数据库。
Nucleic Acids Res. 2022 Jan 7;50(D1):D150-D160. doi: 10.1093/nar/gkab952.
8
Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by Virotherapy.巨噬细胞与肿瘤微环境细胞的相互作用及病毒疗法对癌症中巨噬细胞的调节
Biomedicines. 2021 Sep 24;9(10):1309. doi: 10.3390/biomedicines9101309.
9
Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death.对 P-糖蛋白抑制剂的深入了解:免疫原性细胞死亡的新诱导剂。
Cells. 2020 Apr 22;9(4):1033. doi: 10.3390/cells9041033.
10
Antitumor Effect of a Novel Spiro-Acridine Compound is Associated with Up-Regulation of Th1-Type Responses and Antiangiogenic Action.新型螺环吖啶化合物的抗肿瘤作用与 Th1 型反应的上调和抗血管生成作用有关。
Molecules. 2019 Dec 20;25(1):29. doi: 10.3390/molecules25010029.
Biochim Biophys Acta Proteins Proteom. 2019 Jun;1867(6):637-644. doi: 10.1016/j.bbapap.2019.01.010. Epub 2019 Jan 30.
4
Binding Study of the Fluorescent Carbazole Derivative with Human Telomeric G-Quadruplexes.与人类端粒 G-四链体结合的荧光咔唑衍生物的研究。
Molecules. 2018 Nov 30;23(12):3154. doi: 10.3390/molecules23123154.
5
HMGB1 binds to the KRAS promoter G-quadruplex: a new player in oncogene transcriptional regulation?HMGB1 与 KRAS 启动子 G-四链体结合:致癌基因转录调控的新成员?
Chem Commun (Camb). 2018 Aug 21;54(68):9442-9445. doi: 10.1039/c8cc03614d.
6
Targeting G-quadruplex DNA structures in the telomere and oncogene promoter regions by benzimidazole‒carbazole ligands.通过苯并咪唑-咔唑配体靶向端粒和癌基因启动子区域的 G-四链体 DNA 结构。
Eur J Med Chem. 2018 Mar 25;148:178-194. doi: 10.1016/j.ejmech.2018.01.091. Epub 2018 Feb 5.
7
The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy.免疫原性细胞死亡与癌症免疫治疗中的未折叠蛋白反应
Trends Cancer. 2017 Sep;3(9):643-658. doi: 10.1016/j.trecan.2017.07.002. Epub 2017 Aug 2.
8
DNA Damage and Repair Biomarkers of Immunotherapy Response.免疫治疗反应的DNA损伤与修复生物标志物
Cancer Discov. 2017 Jul;7(7):675-693. doi: 10.1158/2159-8290.CD-17-0226. Epub 2017 Jun 19.
9
Dying cells actively regulate adaptive immune responses.垂死的细胞积极调节适应性免疫反应。
Nat Rev Immunol. 2017 Apr;17(4):262-275. doi: 10.1038/nri.2017.9. Epub 2017 Mar 13.
10
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.CX-5461 是一种 DNA G-四链体稳定剂,对 BRCA1/2 缺陷型肿瘤具有选择性致死作用。
Nat Commun. 2017 Feb 17;8:14432. doi: 10.1038/ncomms14432.